These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23142459)

  • 1. Purification of antibodies to O antigen of Salmonella Typhimurium from human serum by affinity chromatography.
    O'Shaughnessy CM; Micoli F; Gavini M; Goodall M; Cobbold M; Saul A; Maclennan CA
    J Immunol Methods; 2013 Jan; 387(1-2):199-210. PubMed ID: 23142459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens.
    Rondini S; Lanzilao L; Necchi F; O'Shaughnessy CM; Micoli F; Saul A; MacLennan CA
    Microb Pathog; 2013 Oct; 63():19-23. PubMed ID: 23756206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from Kenya.
    Onsare RS; Micoli F; Lanzilao L; Alfini R; Okoro CK; Muigai AW; Revathi G; Saul A; Kariuki S; MacLennan CA; Rondini S
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003573. PubMed ID: 25739091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
    PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on Sugar-Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines.
    De Benedetto G; Salvini L; Gotta S; Cescutti P; Micoli F
    Bioconjug Chem; 2018 May; 29(5):1736-1747. PubMed ID: 29697244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
    Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive African nontyphoidal Salmonella requires high levels of complement for cell-free antibody-dependent killing.
    Goh YS; MacLennan CA
    J Immunol Methods; 2013 Jan; 387(1-2):121-9. PubMed ID: 23085530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults.
    MacLennan CA; Gilchrist JJ; Gordon MA; Cunningham AF; Cobbold M; Goodall M; Kingsley RA; van Oosterhout JJ; Msefula CL; Mandala WL; Leyton DL; Marshall JL; Gondwe EN; Bobat S; López-Macías C; Doffinger R; Henderson IR; Zijlstra EE; Dougan G; Drayson MT; MacLennan IC; Molyneux ME
    Science; 2010 Apr; 328(5977):508-12. PubMed ID: 20413503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation of monospecific Salmonella anti-O-4 antibodies by affinity chromatography and their use in immunoenzyme reactions].
    Iankina NF; Semenova GB
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):79-82. PubMed ID: 2446449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.
    Ramachandran G; Boyd MA; MacSwords J; Higginson EE; Simon R; Galen JE; Pasetti MF; Levine MM; Tennant SM
    Clin Vaccine Immunol; 2016 Jun; 23(6):520-523. PubMed ID: 27030587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella.
    Goh YS; Clare S; Micoli F; Saul A; Mastroeni P; MacLennan CA
    Infect Immun; 2015 Sep; 83(9):3722-31. PubMed ID: 26169269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines.
    Stefanetti G; Rondini S; Lanzilao L; Saul A; MacLennan CA; Micoli F
    Vaccine; 2014 Oct; 32(46):6122-9. PubMed ID: 25192974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Maternally Acquired Antibody in Providing Protective Immunity Against Nontyphoidal Salmonella in Urban Vietnamese Infants: A Birth Cohort Study.
    de Alwis R; Tu LTP; Quynh NLT; Thompson CN; Anders KL; Van Thuy NT; Hieu NT; Vi LL; Chau NVV; Duong VT; Chau TTH; Tuyen HT; Nga TVT; Minh PV; Tan TV; Thu TNH; Nhu TDH; Thwaites GE; Simmons C; Baker S
    J Infect Dis; 2019 Jan; 219(2):295-304. PubMed ID: 30321351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Salmonella Typhimurium core oligosaccharide and its reducing end 3-deoxy-d-manno-oct-2-ulosonic acid used for conjugate vaccine production.
    De Benedetto G; Micoli F; Londero S; Salvini L; Sturiale L; Garozzo D; Ravenscroft N; Giannelli C; Cescutti P
    Carbohydr Res; 2019 Jul; 481():43-51. PubMed ID: 31228656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The O-Antigen Capsule of Salmonella enterica Serovar Typhimurium Facilitates Serum Resistance and Surface Expression of FliC.
    Marshall JM; Gunn JS
    Infect Immun; 2015 Oct; 83(10):3946-59. PubMed ID: 26195553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of O:4 antigen-antibody affinity level in O:5 antigen positive and negative variants of Salmonella enterica serovar Typhimurium.
    Nakai Y; Ito A; Ogawa Y; Aribam SD; Elsheimer-Matulova M; Shiraiwa K; Kisaka SMB; Hikono H; Nishikawa S; Akiba M; Kawahara K; Shimoji Y; Eguchi M
    FEMS Microbiol Lett; 2017 Apr; 364(7):. PubMed ID: 28369258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.
    Baliban SM; Yang M; Ramachandran G; Curtis B; Shridhar S; Laufer RS; Wang JY; Van Druff J; Higginson EE; Hegerle N; Varney KM; Galen JE; Tennant SM; Lees A; MacKerell AD; Levine MM; Simon R
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005493. PubMed ID: 28388624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential timing of antibody-mediated phagocytosis and cell-free killing of invasive African Salmonella allows immune evasion.
    Siggins MK; O'Shaughnessy CM; Pravin J; Cunningham AF; Henderson IR; Drayson MT; MacLennan CA
    Eur J Immunol; 2014 Apr; 44(4):1093-8. PubMed ID: 24375424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States.
    Trebicka E; Jacob S; Pirzai W; Hurley BP; Cherayil BJ
    Clin Vaccine Immunol; 2013 Oct; 20(10):1491-8. PubMed ID: 23803904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.